WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Christina Hoong
Associate
Patents and Innovations
Century City
choong@wsgr.com

D858-350-2206

Download vCard
Open PDF

Dr. Christina Hoong is an associate in the Century City office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm's patents and innovations group. She focuses on patent prosecution and intellectual property. Christina assists on strategic patent counseling in life sciences and biotechnology, organic and medicinal chemistry, and pharmaceuticals.

Prior to joining the firm, Christina performed her doctoral research on synthesis and design of organometallic compounds and studied the therapeutic effects in cancer. In addition, she has studied using silica nanoparticles for targeted delivery to cancer. Christina’s undergraduate research focused on utilizing transition metals, such as gold, for asymmetric catalysis of small molecules.

Experience

Dr. Christina Hoong is an associate in the Century City office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm's patents and innovations group. She focuses on patent prosecution and intellectual property. Christina assists on strategic patent counseling in life sciences and biotechnology, organic and medicinal chemistry, and pharmaceuticals.

Prior to joining the firm, Christina performed her doctoral research on synthesis and design of organometallic compounds and studied the therapeutic effects in cancer. In addition, she has studied using silica nanoparticles for targeted delivery to cancer. Christina’s undergraduate research focused on utilizing transition metals, such as gold, for asymmetric catalysis of small molecules.

Education
  • J.D., University of San Diego School of Law
  • Ph.D., Chemistry and Biochemistry, University of California, San Diego
  • B.S., Chemical Biology, University of California, Berkeley
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of San Diego School of Law
  • Ph.D., Chemistry and Biochemistry, University of California, San Diego
  • B.S., Chemical Biology, University of California, Berkeley
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with Y-M. Wang, J. Wu, V. Rauniyar, and F. D. Toste, “Enantioselective Halocyclization Using Reagents Tailored for Chiral Anion Phase-Transfer Catalysis,” 134(31) J. Am. Chem. Soc. 12928-12931, 2012
  • Co-author with Y-M. Wang, C. N. Kuzniewski, V. Rauniyar, and F. D. Toste, “Chiral (Acyclic Diaminocarbene)Gold(I)-Catalyzed Dynamic Kinetic Asymmetric Transformation of Propargyl Esters,”133 (33) J. Am. Chem. Soc. 12972-12975, 2011
Insights

Select Publications

  • Co-author with Y-M. Wang, J. Wu, V. Rauniyar, and F. D. Toste, “Enantioselective Halocyclization Using Reagents Tailored for Chiral Anion Phase-Transfer Catalysis,” 134(31) J. Am. Chem. Soc. 12928-12931, 2012
  • Co-author with Y-M. Wang, C. N. Kuzniewski, V. Rauniyar, and F. D. Toste, “Chiral (Acyclic Diaminocarbene)Gold(I)-Catalyzed Dynamic Kinetic Asymmetric Transformation of Propargyl Esters,”133 (33) J. Am. Chem. Soc. 12972-12975, 2011

Biological Sciences and Biotechnology

  • Biochemistry
  • Bioconjugation
  • Cancer biology
  • Cancer therapeutics

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug conjugates based drug discovery
  • Drug delivery
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Chemoenzymatic synthesis
  • Nanochemistry
  • Organic chemistry
  • Organometallics
  • Peptidomimetics
  • Polymers
  • Polymorph
  • Supramolecular chemistry

Miscellaneous

  • Cancer
  • Formulations
Technical Fluency

Biological Sciences and Biotechnology

  • Biochemistry
  • Bioconjugation
  • Cancer biology
  • Cancer therapeutics

Therapeutics and Drug Discovery

  • Drug conjugates
  • Drug conjugates based drug discovery
  • Drug delivery
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Chemoenzymatic synthesis
  • Nanochemistry
  • Organic chemistry
  • Organometallics
  • Peptidomimetics
  • Polymers
  • Polymorph
  • Supramolecular chemistry

Miscellaneous

  • Cancer
  • Formulations
Focus Areas
  • Biotech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Alerts
Failure to Provide Correct Inventors to the USPTO Results in Unenforceable Patents
Executive Summary
Learn More
Client Highlights
Wilson Sonsini Advises Loyal on Patent Matters Related to $45 Million Series B
On March 21, 2024, Loyal for Dogs (Loyal), a biotech company pioneering longevity drugs for dogs, announced the completion of a $45 million Series B funding round led by Bain Capital Ventures. Wilson Sonsini Goodrich & Rosati advised Loyal on patent matters related to the Series B and represents the company in patent strategy and prosecution matters.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.